全球 MicroRNA 市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

全球 MicroRNA 市場需求預計將從 2023 年的 24.5 億美元增至 2032 年的近 74.9 億美元，2024-2032 年研究期間複合CAGR為 13.24%。

MicroRNA (miRNA) 是非編碼 RNA 分子，通常由約 20-22 個核苷酸組成，透過與特定信使 RNA (mRNA) 分子結合發揮作用，從而影響其穩定性和翻譯成蛋白質。這些短 RNA 序列有助於基因表現的調節。

市場動態

microRNA 市場是由分子生物學研究領域不斷擴大所推動的，重點在於 microRNA 在基因調控中的複雜作用。人們越來越認知到 microRNA 作為疾病（特別是癌症和心血管疾病）有價值的生物標記物，有助於將其涵蓋研究和診斷。定序技術的進步實現了 microRNA 表現譜的高通量分析，促進了研究和臨床應用的採用。 microRNA 的診斷和治療潛力推動了市場的發展，促進了藥物開發、標靶發現和個人化醫療的探索。正在進行的癌症研究強調了 microRNA 在腫瘤學中的重要性，進一步推動了市場成長。政府資助、合作計劃和檢測方法的技術創新增強了 microRNA 研究工具的能力和範圍。隨著慢性病發病率的上升，人們對了解 microRNA 在疾病發病機制中的作用的需求不斷增加，從而推動了 microRNA 市場的擴張。隨著該領域的不斷發展，microRNA 研究有望推動不同醫療應用的診斷和治療。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球微生物市場的每個細分市場進行了包容性評估。微米產業的成長和趨勢為本研究提供了整體方法。

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲地區 MicroRNA 市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。 MicroRNA市場的主要參與者包括Thermo Fisher Scientific Inc.、QIAGEN、Horizo​​n Discovery Group plc、NanoString Technologies, Inc.、Merck KGaA、Takara Bio Inc.、LGC Limited、BioGenex、GeneCopoeia Inc、New England Biolabs。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

• 報告說明
  • 客觀的
  • 目標受眾
  • 獨特的銷售主張 (USP) 和產品
• 研究範圍
• 研究方法論
  • 市場研究過程
  • 市場研究方法論

第 2 章：執行摘要

• 市場亮點
• 全球市場概況

第 3 章：MICRORNA - 產業分析

• 簡介 - 市場動態
• 市場促進因素
• 市場限制
• 機會
• 產業動態
• 波特五力分析
• 市場吸引力分析
  • 按產品和服務分類的市場吸引力分析
  • 市場吸引力分析：依應用分類
  • 按最終用途分類的市場吸引力分析
  • 市場吸引力分析：按地區

第 4 章：價值鏈分析

• 價值鏈分析
• 原料分析
  • 原料清單
  • 原料廠商清單
  • 主要原物料價格走勢
• 潛在買家名單
• 行銷管道
  • 直效行銷
  • 間接行銷
  • 行銷通路發展趨勢

第 5 章：全球 MICRORNA 市場分析：依產品與服務分類

• 產品和服務概覽
• 歷史和預測數據
• 按產品和服務分析
• 服務（類型、樣本）
• 產品（儀器、工作流程、消耗品、全血）

第 6 章：全球 MICRORNA 市場分析：依應用分類

• 概述：按應用
• 歷史和預測數據
• 分析：按應用
• 癌症
• 傳染性疾病
• 免疫失調
• 心血管疾病
• 神經系統疾病
• 其他

第 7 章：全球 MICRORNA 市場分析：依最終用途分類

• 按最終用途分類的概述
• 歷史和預測數據
• 按最終用途分析
• 生技與製藥公司
• 學術和政府研究機構
• 其他

第 8 章：全球 MICRORNA 市場分析：依地理位置

• 區域展望
• 介紹
• 北美銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 北美按細分市場銷售分析
  • 北美按國家銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 歐洲按細分市場銷售分析
  • 歐洲按國家銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 義大利銷售分析
  • 俄羅斯銷售分析
  • 歐洲其他地區銷售分析
• 亞太地區銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 亞太地區按細分市場銷售分析
  • 亞太地區國家/地區銷售分析
  • 中國銷售分析
  • 印度銷售分析
  • 日本銷售分析
  • 韓國銷售分析
  • 澳洲銷售分析
  • 東南亞銷售分析
  • 亞太地區其他地區銷售分析
• 拉丁美洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 拉丁美洲按細分市場銷售分析
  • 拉丁美洲按國家銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利銷售分析
  • 拉丁美洲其他地區銷售分析
• 中東和非洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 中東和非洲按細分市場銷售分析
  • 中東和非洲國家銷售分析
  • 沙烏地阿拉伯銷售分析
  • 阿拉伯聯合大公國銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 中東其他地區和非洲銷售分析

第 9 章：MICRORNA 公司的競爭格局

• 微米市場競爭
• 夥伴關係/協作/協議
• 併購
• 新產品發布
• 其他發展

第 10 章：公司簡介

• 公司股份分析
• 市場集中度
• Thermo Fisher Scientific Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• QIAGEN
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Horizon Discovery Group plc
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• NanoString Technologies Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Merck KGaA
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Takara Bio Inc
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• LGC Limited
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• BioGenex
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• GeneCopoeia Inc
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• New England Biolabs
• 公司簡介
• 公司收入
• 產品
• 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

The global demand for MicroRNA Market is presumed to reach the market size of nearly USD 7.49 BN by 2032 from USD 2.45 BN in 2023 with a CAGR of 13.24% under the study period 2024 - 2032.

MicroRNA (miRNA) are non-coding RNA molecules typically consisting of about 20-22 nucleotides that function by binding to specific messenger RNA (mRNA) molecules, thereby influencing their stability and translation into proteins. These short RNA sequences assist in the regulation of gene expression.

MARKET DYNAMICS

The microRNA market is driven by the expanding landscape of molecular biology research, with a focus on the intricate role of microRNAs in gene regulation. Increasing awareness of microRNAs as valuable biomarkers for diseases, particularly in cancer and cardiovascular disorders, contributes to their integration into research and diagnostics. Advancements in sequencing technologies enable high-throughput analysis of microRNA expression profiles, fostering adoption in research and clinical applications. The market is propelled by the diagnostic and therapeutic potential of microRNAs, prompting exploration in drug development, target discovery, and personalized medicine. Ongoing cancer research emphasizes the significance of microRNAs in oncology, further fueling market growth. Government funding, collaborative initiatives, and technological innovations in detection methods enhance the capabilities and reach of microRNA research tools. With the rising incidence of chronic diseases, there is an increased demand for understanding the role of microRNAs in disease pathogenesis, driving the expansion of the microRNA market. As the field continues to evolve, microRNA research holds promise for advancing diagnostics and therapeutics across diverse medical applications.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of microrna. The growth and trends of microrna industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the microrna market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Products & Services

• Services (Type, Specimen)
• Products (Instruments, Workflow, Consumables, Whole Blood)

By Application

• Cancer
• Infectious Diseases
• Immunological Disorder
• Cardiovascular Disease
• Neurological Disease
• Others

By End-Use

• Biotechnology & Pharmaceutical Companies
• Academic & Government Research Institutes
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the MicroRNA market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the MicroRNA market include Thermo Fisher Scientific Inc., QIAGEN, Horizon Discovery Group plc, NanoString Technologies, Inc., Merck KGaA, Takara Bio Inc, LGC Limited, BioGenex, GeneCopoeia Inc, New England Biolabs. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . MICRORNA - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Products & Services
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-use
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL MICRORNA MARKET ANALYSIS BY PRODUCTS & SERVICES

• 5.1 Overview by Products & Services
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Products & Services
• 5.4 Services (Type, Specimen) Historic and Forecast Sales by Regions
• 5.5 Products (Instruments, Workflow, Consumables, Whole Blood) Historic and Forecast Sales by Regions

6 . GLOBAL MICRORNA MARKET ANALYSIS BY APPLICATION

• 6.1 Overview by Application
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Application
• 6.4 Cancer Historic and Forecast Sales by Regions
• 6.5 Infectious Diseases Historic and Forecast Sales by Regions
• 6.6 Immunological Disorder Historic and Forecast Sales by Regions
• 6.7 Cardiovascular Disease Historic and Forecast Sales by Regions
• 6.8 Neurological Disease Historic and Forecast Sales by Regions
• 6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL MICRORNA MARKET ANALYSIS BY END-USE

• 7.1 Overview by End-use
• 7.2 Historical and Forecast Data
• 7.3 Analysis by End-use
• 7.4 Biotechnology & Pharmaceutical Companies Historic and Forecast Sales by Regions
• 7.5 Academic & Government Research Institutes Historic and Forecast Sales by Regions
• 7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL MICRORNA MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. South East Asia Sales Analysis
  • 8.5.10. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE MICRORNA COMPANIES

• 9.1. Microrna Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF MICRORNA INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Thermo Fisher Scientific Inc.
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. QIAGEN
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Horizon Discovery Group plc
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. NanoString Technologies Inc.
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Merck KGaA
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Takara Bio Inc
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. LGC Limited
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. BioGenex
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. GeneCopoeia Inc
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. New England Biolabs
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Products & Services (USD MN)
• Services (Type, Specimen) Market Sales by Geography (USD MN)
• Products (Instruments, Workflow, Consumables, Whole Blood) Market Sales by Geography (USD MN)
• Analysis Market by Application (USD MN)
• Cancer Market Sales by Geography (USD MN)
• Infectious Diseases Market Sales by Geography (USD MN)
• Immunological Disorder Market Sales by Geography (USD MN)
• Cardiovascular Disease Market Sales by Geography (USD MN)
• Neurological Disease Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis by End-use (USD MN)
• Biotechnology & Pharmaceutical Companies Market Sales by Geography (USD MN)
• Academic & Government Research Institutes Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Microrna Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Microrna Report
• Market Research Process
• Market Research Methodology
• Global Microrna Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Products & Services
• Market Attractiveness Analysis by Application
• Market Attractiveness Analysis by End-use
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Products & Services (USD MN)
• Services (Type, Specimen) Market Sales by Geography (USD MN)
• Products (Instruments, Workflow, Consumables, Whole Blood) Market Sales by Geography (USD MN)
• Global Market Analysis by Application (USD MN)
• Cancer Market Sales by Geography (USD MN)
• Infectious Diseases Market Sales by Geography (USD MN)
• Immunological Disorder Market Sales by Geography (USD MN)
• Cardiovascular Disease Market Sales by Geography (USD MN)
• Neurological Disease Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by End-use (USD MN)
• Biotechnology & Pharmaceutical Companies Market Sales by Geography (USD MN)
• Academic & Government Research Institutes Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.